Toxicity of bevacizumab in combination with chemotherapy in older patients - Wikidata - awgldk - TriplyDB

Toxicity of bevacizumab in combination with chemotherapy in older patients

Toxicity of bevacizumab in combination with chemotherapy in older patients

http://www.wikidata.org/entity/Q36804502

about

Chemotherapy of ovarian cancer in elderly patients Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the O Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015 Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer Palliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experience Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.Bevacizumab in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for first-line and maintenance treatment of metastatic colorectal cancer.The Role of Wnt Signalling in Angiogenesis.Changes in T lymphocyte subsets in mice with CT26 colon tumors after treatment with donor lymphocyte infusion.

P2860

Q26771397-4AA77230-1A8F-4E7C-8627-81EF368D1832 Q35834442-09318E95-884D-4236-BFF4-502292789A00 Q36017434-D7A3ED6E-0D38-4BDA-8CFA-4CAEB06F7329 Q36073707-A9BE0297-9B62-43F8-A0D7-9C42BD8905A4 Q36169867-D0308249-02BD-4138-A02D-598ADE8A33F5 Q37242517-B62FE662-4E67-4E53-ACD6-5337ABB8D7C3 Q38307997-F576EF32-86B1-4561-9AEB-4C0A01E832A1 Q38617495-D53CD325-0202-4A5A-8E71-F8F0CF178769 Q47553825-014DE53E-F56F-4FC9-A898-AD7AAE6BDA02 Q51746561-AD042CA8-C52D-46E6-A007-B4A4FEC98CDA

P2860

Toxicity of bevacizumab in combination with chemotherapy in older patients

http://www.wikidata.org/entity/Q36804502

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Toxicity of bevacizumab in combination with chemotherapy in older patients

@ast

Toxicity of bevacizumab in combination with chemotherapy in older patients

@en

type

label

Toxicity of bevacizumab in combination with chemotherapy in older patients

@ast

Toxicity of bevacizumab in combination with chemotherapy in older patients

@en

prefLabel

Toxicity of bevacizumab in combination with chemotherapy in older patients

@ast

Toxicity of bevacizumab in combination with chemotherapy in older patients

@en

P1433

Q36804502-42759FCB-09A2-4479-9734-E728125B7626

P1476

Q36804502-6876C0D0-B6DD-4022-9DD2-A6807F3767BD

P2093

Q36804502-0650C72F-0580-454A-A305-7C120F79245D

Q36804502-24D635AF-72F8-4C7A-8BAC-B1BB240AB9DE

Q36804502-5E244AB3-CCE4-4136-9AE4-1F0B02D2883A

Q36804502-6E54B349-EEE2-44DC-A29A-3FEAB5A876C7

Q36804502-6F4483AE-FA24-4614-B2A0-5999C6F56ADF

Q36804502-7E6116E4-9307-45FA-B0B9-B77BF62F7FB2

Q36804502-8B3E482A-9725-427B-83CB-24D8260E6E05

Q36804502-8E97A3CB-7CA1-4179-9F9C-69F9146DFB3D

Q36804502-B7223E7D-5B39-4EED-A637-0F472F54B38E

Q36804502-C1235834-ECBE-481D-A877-1070E54F960D

P2860

Q36804502-08CC6910-1CD6-41C0-8AB2-D0082C7A61D9

Q36804502-1DAD6FD9-53B9-4248-8A5A-4C35F05F1D9A

Q36804502-21CFA890-ED86-4E50-B192-2BB74638E252

Q36804502-21D5899F-80E1-4D17-8884-440C94E8BA0C

Q36804502-22564D37-1A34-41E8-B7AF-F3081FB6DA2B

Q36804502-246D4F81-C2C5-48A2-A2CF-86E464C395E6

Q36804502-26B431A6-0C00-48CD-BDD3-F7E7457B5D60

Q36804502-2F70DF6D-3B1F-4023-A2E7-0E0BC9B33FA1

Q36804502-3509DDAB-2FE3-4FEC-8FAD-D93627F9FAE0

Q36804502-4EA1F03A-B620-4D1F-A9AE-CB557C6AD489

P304

Q36804502-2FC54D43-FBBB-45F6-BBCF-E8CEFBC9A02B

P31

Q36804502-B4FC297B-18C5-4DD8-B823-690028B8E4AB

P356

Q36804502-A10B141D-241F-4CDB-963D-9D6CFA63E25E

P433

Q36804502-249A7F9E-D46C-423F-BF9C-D6BE0B7FB2FE

P478

Q36804502-742BF588-8E92-4FEB-A1AD-358D5792D3D9

P50

Q36804502-D6418F4D-2275-4629-B188-C4B418459A02

P577

Q36804502-9E9A5456-C2B8-4A5F-80C6-61272EB1614F

P5875

Q36804502-CF296EE0-0ECD-4516-9A0B-321811A8BFDA

P698

Q36804502-36468158-0CAD-4236-8036-34EBEA28844C

P921

Q36804502-AB69D3AA-9ED4-4A65-A341-87CEEFCD535F

Q36804502-D0C46AD5-14F0-488D-835D-7CEE207E3AA7

P932

Q36804502-A78C9E91-E020-4DCF-AED1-98C8C49E24AC

P356

THEONCOLOGIST.2012-0351

P1433

P1476

Toxicity of bevacizumab in combination with chemotherapy in older patients

@en

P2093

Ajeet Gajra

http://www.w3.org/2001/XMLSchema#string

Arti Hurria

http://www.w3.org/2001/XMLSchema#string

Cancer and Aging Research Group

http://www.w3.org/2001/XMLSchema#string

Cary Gross

http://www.w3.org/2001/XMLSchema#string

Cynthia Owusu

http://www.w3.org/2001/XMLSchema#string

Heidi Klepin

http://www.w3.org/2001/XMLSchema#string

Kayo Togawa

http://www.w3.org/2001/XMLSchema#string

Kurt Hansen

http://www.w3.org/2001/XMLSchema#string

Molly Hardt

http://www.w3.org/2001/XMLSchema#string

Rupal Ramani

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.

Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer

Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials.

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis.

P304

408-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2012-0351

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Stuart M Lichtman

P577

2013-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262042881

http://www.w3.org/2001/XMLSchema#string

P698

23576485

http://www.w3.org/2001/XMLSchema#string

P921

P932

3639527

http://www.w3.org/2001/XMLSchema#string